Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT02396459Phase 2Active Not Recruiting
Triac Trial II in MCT8 Deficiency Patients
Allan-Herndon-Dudley Syndrome
PrincipalinvestigatorStart date: 2020-12-07

Research Network

Collaboration Network

6 collaborators·15 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Charles University and Motol University Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Andrew J. Bauer, MD

Children's Hospital of Philadelphia

Moderately Similar
1 trials

Shared therapeutic areas:

Allan-Herndon-Dudley SyndromeMonocarboxylate Transporter 8 (MCT8) Deficiency

Worked with same sponsors:

Rare Thyroid Therapeutics International AB
Similarity Score30%

W. E. Visser, MD

Erasmus Medical Center

Moderately Similar
1 trials

Shared therapeutic areas:

Allan-Herndon-Dudley SyndromeMonocarboxylate Transporter 8 (MCT8) Deficiency

Worked with same sponsors:

Rare Thyroid Therapeutics International AB
Similarity Score30%

Mark Larkin, PhD

Vitaccess Limited

Moderately Similar
1 trials

Shared therapeutic areas:

Allan-Herndon-Dudley SyndromeMonocarboxylate Transporter 8 (MCT8) Deficiency

Worked with same sponsors:

Rare Thyroid Therapeutics International AB
Similarity Score30%

Andrew Bauer, MD

Children's Hospital of Philadelphia

Related
1 trials

Shared therapeutic areas:

Allan-Herndon-Dudley SyndromeMonocarboxylate Transporter 8 (MCT8) Deficiency

Worked with same sponsors:

Erasmus Medical CenterRare Thyroid Therapeutics International AB
Collaborated on 1 trial
Similarity Score24%

Heiko Krude

Charité - Universitätsmedizin Berlin Institut fur experimental paediatrische endokrinologie

Related
1 trials

Shared therapeutic areas:

Allan-Herndon-Dudley SyndromeMonocarboxylate Transporter 8 (MCT8) Deficiency

Worked with same sponsors:

Erasmus Medical CenterRare Thyroid Therapeutics International AB
Collaborated on 1 trial
Similarity Score24%

W.E. Visser, MD, PhD

Erasmus Medical Center

Related
1 trials

Shared therapeutic areas:

Allan-Herndon-Dudley SyndromeMonocarboxylate Transporter 8 (MCT8) Deficiency

Worked with same sponsors:

Erasmus Medical CenterRare Thyroid Therapeutics International AB
Collaborated on 1 trial
Similarity Score24%

Lindsey Nicol

Oregon Health& Science University (OHSU) Doernbecher Childrens Hospital

Related
1 trials

Shared therapeutic areas:

Allan-Herndon-Dudley SyndromeMonocarboxylate Transporter 8 (MCT8) Deficiency

Worked with same sponsors:

Erasmus Medical CenterRare Thyroid Therapeutics International AB
Collaborated on 1 trial
Similarity Score24%

Kristina Sjöblom Nygren, MD

Rare Thyroid Therapeutics International AB

Related
1 trials

Shared therapeutic areas:

Allan-Herndon-Dudley SyndromeMonocarboxylate Transporter 8 (MCT8) Deficiency

Worked with same sponsors:

Erasmus Medical CenterRare Thyroid Therapeutics International AB
Collaborated on 1 trial
Similarity Score24%

Heiko Krude, MD

Charite University, Berlin, Germany

Related
1 trials

Shared therapeutic areas:

Allan-Herndon-Dudley Syndrome
Similarity Score15%

W.E. Visser, dr,

Erasmus Medical Center

Related
1 trials

Shared therapeutic areas:

Allan-Herndon-Dudley Syndrome

Worked with same sponsors:

Erasmus Medical Center
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02396459Phase 2PrincipalInvestigator

Triac Trial II in MCT8 Deficiency Patients

Allan-Herndon-Dudley Syndrome
Active Not Recruiting

All 1 trials loaded